• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国卫生研究院文献>Cancer Medicine >Phase 1–3 of the cross‐cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ‐22
【2h】

Phase 1–3 of the cross‐cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ‐22

机译：评估癌症患者性健康的EORTC问卷的跨文化开发的第1至第3阶段：EORTC SHQ-22

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To develop and pretest an European Organization for the Research and Treatment of Cancer Sexual Health Questionnaire (EORTC SHQ‐22) for the assessment of physical, psychological, and social aspects of sexual health (SH) in male and female cancer patients and survivors. Questionnaire construction started with creating a list of relevant SH issues based on a comprehensive literature review. Issues were subsequently evaluated for relevance and prioritization by 78 healthcare professionals (HCP) and 107 patients from 12 countries during in‐depth interviews (phase 1). Extracted issues were operationalized into items (phase 2). Phase 3 focused on pretesting the preliminary questionnaire in a cross‐cultural patient sample (n = 171) using debriefing interviews. Psychometric properties were preliminary determined using a principal component analysis and Cronbach's alpha. We derived 53 relevant SH issues from the literature. Based on HCP and patient interviews, 22 of these 53 issues were selected and operationalized into items. Testing the preliminary 22‐item short questionnaire resulted in a change of wording in five items and two communication‐related items; no items were removed. Preliminary psychometric analysis revealed a two‐factor solution and 11 single items; both scales showed good reliability indicated by a Cronbach's alpha of 0.87 (sexual satisfaction) and 0.82 (sexual pain). Cross‐cultural pretesting of the preliminary EORTC SH questionnaire has indicated excellent applicability, patient acceptance, and comprehensiveness as well as good psychometric properties. The final development phase, that is psychometric validation (phase four) including large‐scale, cross‐cultural field testing of the EORTC SHQ‐22, has commenced.
机译：开发和预测试欧洲癌症性健康研究和治疗组织（EORTC SHQ-22），以评估男性和女性癌症患者和幸存者的性健康（SH）的身体，心理和社会方面。问卷调查的建立始于在全面的文献综述的基础上创建相关的SH问题列表。随后，在深度访谈中（第1阶段），由来自12个国家的78名医疗保健专业人员（HCP）和107名患者对这些问题进行了相关性分析和优先级评估。提取的问题已投入项目（阶段2）。第三阶段的重点是使用汇报访谈对跨文化患者样本（n = 171）中的初步问卷进行预测试。使用主成分分析和Cronbach's alpha初步确定了心理计量学特性。我们从文献中得出了53个相关的SH问题。基于HCP和患者访谈，在这53个问题中选择了22个并将其实施为项目。测试初步的22个项目的简短问卷会导致五个项目和两个与沟通相关的项目的措辞发生变化；没有任何项目被删除。初步的心理计量学分析显示出两因素解决方案和11个单项。两种量表均显示出良好的信度，Cronbach's alpha为0.87（性满意度）和0.82（性痛）。初步EORTC SH问卷的跨文化预测试显示出极好的适用性，患者接受度和全面性以及良好的心理计量学特性。最终的开发阶段已开始，即心理计量学验证（第四阶段），包括对EORTC SHQ-22进行大规模，跨文化的现场测试。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号